- Graduate School - UT Southwestern Medical School (2010-2013)
- Residency - Montefiore Medical Center/ Albert Einstein College of Medicine (1999-2006), General Surgery
- Medical School - Rutgers Robert Wood Johnson Medical School (1995-1999)
- Fellowship - University of Chicago Medical Center (2006-2009), Surgical Oncology
Rohit Sharma, M.D.
- Surgery - Surgical Oncology
- Skin Cancer
- Soft Tissue Sarcoma
Rohit Sharma, M.D., is an Assistant Professor in UT Southwestern Medical Center's Department of Surgery. He is a surgical oncologist at Harold C. Simmons Cancer Center specializing in the treatment of soft-tissue sarcomas, melanomas, and other complex skin cancers.
Dr. Sharma earned his medical degree at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, and completed a general surgery residency at Montefiore Medical Center, Albert Einstein College of Medicine in New York.
He joined UT Southwestern's Division of Surgical Oncology in 2009. Prior to that, he served as a Fellow in surgical oncology at the University of Chicago Medical Center.
His research interests include cancer metastasis, tumor immunology, and health care disparities related to melanoma and soft-tissue sarcoma. He also seeks novel therapies for managing sarcomas and related tumors, especially in the areas of combination therapies and evaluating mechanisms of resistance.
Meet Dr. Sharma
But while the technical aspects of his work engage him, he says it's the human side of medicine that makes his efforts worthwhile.
"I love using the skills I have to help people and to address the particular cancer that ails them," Dr. Sharma says.
When Dr. Sharma meets with patients, he makes sure he spends time in person to help them understand their disease and options for treatment. He guides them through the decisions they need to make, from treatment to recovery.
"I want to be a part of the process with them, every step of the way," he says.
Each soft-tissue sarcoma and melanoma case is unique and requires a tailored care strategy. Dr. Sharma credits his Harold C. Simmons Cancer Center’s multidisciplinary approach to treating soft-tissue sarcomas and melanomas for making the cancer center a place where great care is possible.
Discussing cases with his colleagues, Dr. Sharma is able to recommend the best combinations of treatments, from surgery to chemotherapy or radiation therapy. This approach creates a personalized treatment plan for each patient.
Patients also benefit from access to clinical trials that aren't available at other medical centers, Dr. Sharma says. The access UT Southwestern can offer improves each patient's chances of survival. In his own research, Dr. Sharma continually looks at novel therapies for managing soft-tissue sarcomas, melanomas, and related tumors, especially in the areas of combination therapies and evaluating mechanisms of resistance.
- Society of Surgical Oncology
- Society for Melanoma Research
- Association of Academic Surgeons
- American Society of Clinical Oncology
- American College of Surgeons
- Outstanding Resident Teacher Award 2005, Outstanding Resident Teacher, Department of Surgery, Montefiore Medical Center, Alber Einstein College of Medicine
- Golden Apple Award 2006, Best Resident Teacher, Department of Surgery, Montefiore Medical Center, Alber Einstein College of Medicine
Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma
Heitmiller, RF and Sharma, RR J. Thoracic and Cardiovasc. Surg. 1996 112 130-136
HSP70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation
Yang, W-L, Nair, DG, Makizumi, R, Gallos, G, Ye, X, Sharma, RR, and Ravikumar, TS Ann. Surg. Oncol. 2004 11 399-406
Induction of p21WAF1 expression protects colon cancer cells from apoptosis induced by cryoinjury
Sharma, RR, Ravikumar, TS, Raimo, D, and Yang, W-L Ann. Surg. Oncol. 2005 12(9) 743-752
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme
Sharma, RR and Weichselbaum, RR Nat. Clin. Pract. Oncol. 2007 4(8) 454-455
Preemptive surgery for premalignant foregut lesions
Sharma, RR, London, MJ, Magenta, LL, Posner, MC, and Roggin, KK J. Gastrointest. Surg. 2009 13 1874-1887
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment
Lee, Y, Auh, SL, Wang, Y, Burnette, B, Wang, Y, Meng, Y, Beckett, M, Sharma, R, Chin, R, Tu, T, Weichselbaum, RR, and Fu, Y-X Blood 2009 114(3) 589-595
- Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma
- Tumor Immunology
- Cancer Metastasis
- Skin Cancer
- Soft Tissue Sarcoma
- Surgery for Skin Cancer
Q&A by Dr. Sharma
Showing 1 locations